Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,290.40    -21.00 (-1.60%)
Bid:
1,290.20
Ask:
1,290.60
Spread: 0.40 (0.031%)
Market Cap: £221.28b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Transaction in Own Shares

2 Oct 2024 17:58

RNS Number : 7214G
HSBC Holdings PLC
02 October 2024
 

HSBC HOLDINGS PLC

2 October 2024

Transaction in own shares

 

HSBC Holdings plc ("HSBC" or the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of US$0.50 from Merrill Lynch International ("Merrill Lynch") as part of its buy-back announced on 1 August 2024.

UK Venues

Date of purchase:

2 October 2024

Number of ordinary shares of US$0.50 each purchased:

4,992,886 

Highest price paid per share:

£6.7940 

Lowest price paid per share:

£6.7130 

Volume weighted average price paid per share:

£6.7626 

 

All repurchases on the London Stock Exchange, Cboe Europe Limited (through the BXE and CXE order books) and/or Turquoise ("UK Venues") are implemented as "on Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and as "market purchases" for the purposes of the Companies Act 2006.

Hong Kong Stock Exchange

Date of purchase:

2 October 2024

Number of ordinary shares of US$0.50 each purchased:

3,541,200 

Highest price paid per share:

HK$69.8500 

Lowest price paid per share:

HK$69.0000 

Volume weighted average price paid per share:

HK$69.4309 

All repurchases on The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") are "off market" for the purposes of the Companies Act 2006 but are transactions which occur "on Exchange" for the purposes of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and which constitute an "on-market share buy-back" for the purposes of the Codes on Takeovers and Mergers and Share Buy-backs.

Since the commencement of the buy-back announced on 1 August 2024, the Company has repurchased 271,726,552 ordinary shares for a total consideration of approximately US$2,344.4m.

Following the cancellation of the shares repurchased on the UK Venues, the Company's issued ordinary share capital will consist of 18,261,740,369 ordinary shares with voting rights. There are no ordinary shares held in treasury. Cancellation of the shares repurchased on the Hong Kong Stock Exchange takes longer than those repurchased on the UK Venues and a further announcement of total voting rights will be made once those shares have been cancelled.

The above figure of 18,261,740,369 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Merrill Lynch on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/7214G_1-2024-10-2.pdf

This announcement will also be available on HSBC's website at www.hsbc.com/sea

Enquiries to:

Lee DavisCorporate Governance & Secretariat

shareholderquestions@hsbc.com

+44 (0)20 7991 8888

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKBBNABDDBKK
Date   Source Headline
3rd Apr 20255:56 pmRNSTransaction in Own Shares
2nd Apr 20255:48 pmRNSTransaction in Own Shares
1st Apr 20255:52 pmRNSTransaction in Own Shares
31st Mar 20255:42 pmRNSTransaction in Own Shares
31st Mar 20253:00 pmRNSTotal Voting Rights
31st Mar 20252:00 pmRNSBOCOM Proposed Issuance of A Shares
28th Mar 20255:42 pmRNSTransaction in Own Shares
28th Mar 20253:00 pmRNSDirector/PDMR Shareholding
28th Mar 20251:05 pmRNSPublication of Base Prospectus
27th Mar 20255:55 pmRNSTransaction in Own Shares
26th Mar 20256:06 pmRNSTransaction in Own Shares
25th Mar 20255:49 pmRNSTransaction in Own Shares
25th Mar 202510:00 amRNSOverseas Regulatory Announcement - Grant of Awards
24th Mar 20255:46 pmRNSTransaction in Own Shares
24th Mar 20254:00 pmRNSDirector/PDMR Shareholding
24th Mar 20259:00 amRNSSecurities issuance - closing announcement
21st Mar 20255:59 pmRNSTransaction in Own Shares
21st Mar 202510:00 amRNS2025 AGM - Documents available at NSM
21st Mar 20257:00 amRNSIssuance of contingent convertible securities
20th Mar 20256:00 pmRNSTransaction in Own Shares
19th Mar 20255:55 pmRNSTransaction in Own Shares
19th Mar 202510:00 amRNSHong Kong Waiver-Contingent Convertible Securities
18th Mar 20255:45 pmRNSTransaction in Own Shares
17th Mar 20255:33 pmRNSTransaction in Own Shares
14th Mar 20255:48 pmRNSTransaction in Own Shares
13th Mar 20255:35 pmRNSTransaction in Own Shares
13th Mar 20253:30 pmRNSDirector/PDMR Shareholding
12th Mar 20255:40 pmRNSTransaction in Own Shares
12th Mar 20253:30 pmRNSDirector/PDMR Shareholding
11th Mar 20255:48 pmRNSTransaction in Own Shares
11th Mar 20253:10 pmRNSIssuance of subordinated unsecured notes
10th Mar 20255:59 pmRNSTransaction in Own Shares
7th Mar 20255:57 pmRNSTransaction in Own Shares
7th Mar 20253:30 pmRNSNotice of redemption
7th Mar 20259:00 amRNSGroup reporting changes
6th Mar 20255:48 pmRNSTransaction in Own Shares
6th Mar 202511:01 amRNSDirector/PDMR Shareholding
6th Mar 202511:00 amRNSOverseas Regulatory Announcement - Grant of Awards
5th Mar 20255:46 pmRNSTransaction in Own Shares
4th Mar 20255:58 pmRNSTransaction in Own Shares
4th Mar 20254:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20255:33 pmRNSTransaction in Own Shares
3rd Mar 20254:00 pmRNSIssuance of senior unsecured notes
28th Feb 20255:55 pmRNSTransaction in Own Shares
28th Feb 20253:01 pmRNSTotal Voting Rights
28th Feb 20253:00 pmRNSDirector/PDMR Shareholding
27th Feb 20255:57 pmRNSTransaction in Own Shares
27th Feb 20254:35 pmRNSIssuance of contingent convertible securities
26th Feb 20255:52 pmRNSTransaction in Own Shares
25th Feb 20255:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.